Literature DB >> 2591247

APACHE III study design: analytic plan for evaluation of severity and outcome in intensive care unit patients. Implications.

W Knaus, D Wagner, E Draper.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2591247

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  6 in total

1.  Evaluation of APACHE II for cost containment and quality assurance.

Authors:  J M Civetta; J A Hudson-Civetta; L D Nelson
Journal:  Ann Surg       Date:  1990-09       Impact factor: 12.969

2.  Predictors of thirst in intensive care unit patients.

Authors:  Nancy A Stotts; Shoshana R Arai; Bruce A Cooper; Judith E Nelson; Kathleen A Puntillo
Journal:  J Pain Symptom Manage       Date:  2014-08-10       Impact factor: 3.612

3.  Promoting Global Research Excellence in Severe Sepsis (PROGRESS): lessons from an international sepsis registry.

Authors:  R Beale; K Reinhart; F M Brunkhorst; G Dobb; M Levy; G Martin; C Martin; G Ramsey; E Silva; B Vallet; J-L Vincent; J M Janes; S Sarwat; M D Williams
Journal:  Infection       Date:  2009-04-28       Impact factor: 3.553

4.  Supplemental immunoglobulin (ivIgG) treatment in 163 patients with sepsis and septic shock--an observational study as a prerequisite for placebo-controlled clinical trials.

Authors:  G Pilz; S Kääb; G Neeser; I Class; U Schweigart; A Brähler; O Bujdoso; R Neumann; K Werdan
Journal:  Infection       Date:  1991 Jul-Aug       Impact factor: 3.553

5.  Comparison of Charlson comorbidity index with SAPS and APACHE scores for prediction of mortality following intensive care.

Authors:  Steffen Christensen; Martin Berg Johansen; Christian Fynbo Christiansen; Reinhold Jensen; Stanley Lemeshow
Journal:  Clin Epidemiol       Date:  2011-06-17       Impact factor: 4.790

6.  Charlson comorbidity index derived from chart review or administrative data: agreement and prediction of mortality in intensive care patients.

Authors:  Knut Stavem; Henrik Hoel; Stein Arve Skjaker; Rolf Haagensen
Journal:  Clin Epidemiol       Date:  2017-06-02       Impact factor: 4.790
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.